Global Allergic Rhinitis Immunotherapies Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Allergic Rhinitis Immunotherapies Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Subcutaneous Immunotherapy
- 1.4.3 Sublingual Immunotherapy
- 1.5 Market by Application
- 1.5.1 Global Allergic Rhinitis Immunotherapies Market Share by Application (2014-2025)
- 1.5.2 Hospital Pharmacies
- 1.5.3 Online Pharmacies
- 1.5.4 Retail Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Allergic Rhinitis Immunotherapies Market Size
- 2.2 Allergic Rhinitis Immunotherapies Growth Trends by Regions
- 2.2.1 Allergic Rhinitis Immunotherapies Market Size by Regions (2014-2025)
- 2.2.2 Allergic Rhinitis Immunotherapies Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Allergic Rhinitis Immunotherapies Market Size by Manufacturers
- 3.1.1 Global Allergic Rhinitis Immunotherapies Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Allergic Rhinitis Immunotherapies Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Allergic Rhinitis Immunotherapies Market Concentration Ratio (CR5 and HHI)
- 3.2 Allergic Rhinitis Immunotherapies Key Players Head office and Area Served
- 3.3 Key Players Allergic Rhinitis Immunotherapies Product/Solution/Service
- 3.4 Date of Enter into Allergic Rhinitis Immunotherapies Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Allergic Rhinitis Immunotherapies Market Size by Type (2014-2019)
- 4.2 Global Allergic Rhinitis Immunotherapies Market Size by Application (2014-2019)
5 United States
- 5.1 United States Allergic Rhinitis Immunotherapies Market Size (2014-2019)
- 5.2 Allergic Rhinitis Immunotherapies Key Players in United States
- 5.3 United States Allergic Rhinitis Immunotherapies Market Size by Type
- 5.4 United States Allergic Rhinitis Immunotherapies Market Size by Application
6 Europe
- 6.1 Europe Allergic Rhinitis Immunotherapies Market Size (2014-2019)
- 6.2 Allergic Rhinitis Immunotherapies Key Players in Europe
- 6.3 Europe Allergic Rhinitis Immunotherapies Market Size by Type
- 6.4 Europe Allergic Rhinitis Immunotherapies Market Size by Application
7 China
- 7.1 China Allergic Rhinitis Immunotherapies Market Size (2014-2019)
- 7.2 Allergic Rhinitis Immunotherapies Key Players in China
- 7.3 China Allergic Rhinitis Immunotherapies Market Size by Type
- 7.4 China Allergic Rhinitis Immunotherapies Market Size by Application
8 Japan
- 8.1 Japan Allergic Rhinitis Immunotherapies Market Size (2014-2019)
- 8.2 Allergic Rhinitis Immunotherapies Key Players in Japan
- 8.3 Japan Allergic Rhinitis Immunotherapies Market Size by Type
- 8.4 Japan Allergic Rhinitis Immunotherapies Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Allergic Rhinitis Immunotherapies Market Size (2014-2019)
- 9.2 Allergic Rhinitis Immunotherapies Key Players in Southeast Asia
- 9.3 Southeast Asia Allergic Rhinitis Immunotherapies Market Size by Type
- 9.4 Southeast Asia Allergic Rhinitis Immunotherapies Market Size by Application
10 India
- 10.1 India Allergic Rhinitis Immunotherapies Market Size (2014-2019)
- 10.2 Allergic Rhinitis Immunotherapies Key Players in India
- 10.3 India Allergic Rhinitis Immunotherapies Market Size by Type
- 10.4 India Allergic Rhinitis Immunotherapies Market Size by Application
11 Central & South America
- 11.1 Central & South America Allergic Rhinitis Immunotherapies Market Size (2014-2019)
- 11.2 Allergic Rhinitis Immunotherapies Key Players in Central & South America
- 11.3 Central & South America Allergic Rhinitis Immunotherapies Market Size by Type
- 11.4 Central & South America Allergic Rhinitis Immunotherapies Market Size by Application
12 International Players Profiles
- 12.1 Anergis
- 12.1.1 Anergis Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Allergic Rhinitis Immunotherapies Introduction
- 12.1.4 Anergis Revenue in Allergic Rhinitis Immunotherapies Business (2014-2019)
- 12.1.5 Anergis Recent Development
- 12.2 HAL Allergy Group
- 12.2.1 HAL Allergy Group Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Allergic Rhinitis Immunotherapies Introduction
- 12.2.4 HAL Allergy Group Revenue in Allergic Rhinitis Immunotherapies Business (2014-2019)
- 12.2.5 HAL Allergy Group Recent Development
- 12.3 Merck
- 12.3.1 Merck Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Allergic Rhinitis Immunotherapies Introduction
- 12.3.4 Merck Revenue in Allergic Rhinitis Immunotherapies Business (2014-2019)
- 12.3.5 Merck Recent Development
- 12.4 Allergy Therapeutics
- 12.4.1 Allergy Therapeutics Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Allergic Rhinitis Immunotherapies Introduction
- 12.4.4 Allergy Therapeutics Revenue in Allergic Rhinitis Immunotherapies Business (2014-2019)
- 12.4.5 Allergy Therapeutics Recent Development
- 12.5 ALK-Abello
- 12.5.1 ALK-Abello Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Allergic Rhinitis Immunotherapies Introduction
- 12.5.4 ALK-Abello Revenue in Allergic Rhinitis Immunotherapies Business (2014-2019)
- 12.5.5 ALK-Abello Recent Development
- 12.6 Stallergenes Greer
- 12.6.1 Stallergenes Greer Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Allergic Rhinitis Immunotherapies Introduction
- 12.6.4 Stallergenes Greer Revenue in Allergic Rhinitis Immunotherapies Business (2014-2019)
- 12.6.5 Stallergenes Greer Recent Development
- 12.7 Laboratorios LETI
- 12.7.1 Laboratorios LETI Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Allergic Rhinitis Immunotherapies Introduction
- 12.7.4 Laboratorios LETI Revenue in Allergic Rhinitis Immunotherapies Business (2014-2019)
- 12.7.5 Laboratorios LETI Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Allergic rhinitis, sometimes referred to as hay fever, is an inflammatory disease that causes sneezing, itchy or watery eyes, itchy or runny nose and congestion.
In 2018, the global Allergic Rhinitis Immunotherapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Allergic Rhinitis Immunotherapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Allergic Rhinitis Immunotherapies development in United States, Europe and China.
The key players covered in this study
Anergis
HAL Allergy Group
Merck
Allergy Therapeutics
ALK-Abello
Stallergenes Greer
Laboratorios LETI
...
Market segment by Type, the product can be split into
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Allergic Rhinitis Immunotherapies status, future forecast, growth opportunity, key market and key players.
To present the Allergic Rhinitis Immunotherapies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Allergic Rhinitis Immunotherapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.